Ajanta Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE031B01049
  • NSEID: AJANTPHARM
  • BSEID: 532331
INR
2,874.70
87.55 (3.14%)
BSENSE

Feb 03

BSE+NSE Vol: 1.26 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 178818,
    "name": "Ajanta Pharma",
    "stock_name": "Ajanta Pharma",
    "full_name": "Ajanta Pharma Ltd.",
    "name_url": "stocks-analysis/ajanta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,874.70",
    "chg": 87.55,
    "chgp": "3.14%",
    "dir": 1,
    "prev_price": "2,787.15",
    "mcapval": "34,908.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532331,
    "symbol": "AJANTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE031B01049",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.26 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "178818",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/ajanta-pharma-178818"
  },
  "announcements": [
    {
      "caption": "Participation In Investor Conference",
      "datetime": "02-Feb-2026",
      "details": "Pls find enclosed intimation w.r.t Participation in Investor Conference",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Feb-2026",
      "details": "Pls find enclosed newspaper cuttings of Financial results published.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "30-Jan-2026",
      "details": "Pls find enclosed Audio recording of Earnings call conducted on 30th January 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has declared <strong>1400%</strong> dividend, ex-date: 10 Nov 25",
          "dt": "2025-11-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15",
          "dt": "2015-03-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22",
          "dt": "2022-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Participation In Investor Conference

02-Feb-2026 | Source : BSE

Pls find enclosed intimation w.r.t Participation in Investor Conference

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Feb-2026 | Source : BSE

Pls find enclosed newspaper cuttings of Financial results published.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

30-Jan-2026 | Source : BSE

Pls find enclosed Audio recording of Earnings call conducted on 30th January 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Ajanta Pharma Ltd. has declared 1400% dividend, ex-date: 10 Nov 25

stock-summary
SPLITS

Ajanta Pharma Ltd. has announced 2:5 stock split, ex-date: 20 Mar 15

stock-summary
BONUS

Ajanta Pharma Ltd. has announced 1:2 bonus issue, ex-date: 22 Jun 22

stock-summary
RIGHTS

No Rights history available